Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-18-001131
Filing Date
2018-02-01
Accepted
2018-02-01 10:21:35
Documents
1
Period of Report
2018-01-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3.html 3  
1 PRIMARY DOCUMENT doc3.xml 3 1569
  Complete submission text file 0001213900-18-001131.txt   2905
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O IMMUCELL CORPORATION 56 EVERGREEN DR. PORTLAND ME 04103
Business Address
Rosgen Steven T. (Reporting) CIK: 0001729885 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12934 | Film No.: 18565316